Gene Editing Market Size Worth USD 19.4 Billion by 2030 at 14.7% CAGR – Report by Market Research Future (MRFR)
January 17, 2023 09:30 ET
|
Market Research Future
New York, USA, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Gene Editing Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Gene Editing Market Information By...
Gene Therapy Market Size to Surpass USD 3,251.92 Million by 2030 at 19.10% CAGR – Report by Market Research Future (MRFR)
January 02, 2023 09:30 ET
|
Market Research Future
New York, USA, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Gene Therapy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), "Gene Therapy Market Information By...
Fraser Institute News Release: Canadian generosity hits lowest point in 20 years
December 15, 2022 05:00 ET
|
Fraser Institute
VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The number of Canadians donating to charity—as a percentage of all tax filers—is at the lowest point in 20 years, finds a new study...
GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes
December 06, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health,...
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
November 10, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE), a global leader in guideline driven Genomics based tests in health, wellness and serious disease...
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
November 09, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health,...
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
September 29, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
GENE Momentum building - a year in review
August 30, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
Gene achieves key milestones and growth
July 28, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Enzyme Replacement Therapy Market Worth $15.18 Billion by 2028 at 6.8% CAGR Led by Hospitals Segment (49% Market Share in 2021) Global Analysis by The Insight Partners
July 22, 2022 07:35 ET
|
The Insight Partners
New York, July 22, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...